RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 77 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q1 2015. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $10,893,000 | +182.8% | 1,214,418 | +69.2% | 0.01% | +166.7% |
| Q2 2016 | $3,852,000 | +21.1% | 717,543 | +3.7% | 0.00% | +50.0% |
| Q1 2016 | $3,181,000 | -41.4% | 691,661 | -33.8% | 0.00% | -50.0% |
| Q4 2015 | $5,427,000 | +98.1% | 1,044,208 | +130.3% | 0.00% | +100.0% |
| Q3 2015 | $2,740,000 | -59.7% | 453,345 | +5.2% | 0.00% | -50.0% |
| Q2 2015 | $6,803,000 | +22.6% | 431,005 | -15.6% | 0.00% | +33.3% |
| Q1 2015 | $5,551,000 | +321.5% | 510,875 | +307.3% | 0.00% | +200.0% |
| Q4 2014 | $1,317,000 | -3.7% | 125,443 | -12.2% | 0.00% | 0.0% |
| Q3 2014 | $1,368,000 | -2.6% | 142,893 | +17.4% | 0.00% | 0.0% |
| Q2 2014 | $1,405,000 | +153.2% | 121,718 | +119.0% | 0.00% | – |
| Q1 2014 | $555,000 | +15.1% | 55,571 | +49.5% | 0.00% | – |
| Q4 2013 | $482,000 | -63.9% | 37,161 | -58.6% | 0.00% | -100.0% |
| Q3 2013 | $1,336,000 | – | 89,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trellus Management Company, LLC | 63,500 | $1,003,000 | 1.13% |
| Broadfin Capital, LLC | 1,319,883 | $20,841,000 | 1.12% |
| BAILARD, INC. | 160,000 | $2,526,000 | 0.39% |
| Birchview Capital, LP | 46,000 | $726,000 | 0.38% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,182,167 | $18,666,000 | 0.38% |
| Rock Springs Capital Management LP | 305,000 | $4,816,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,500 | $3,261,000 | 0.32% |
| GLOBEFLEX CAPITAL L P | 109,771 | $1,733,000 | 0.32% |
| GROUP ONE TRADING, L.P. | 1,319,766 | $20,839,000 | 0.29% |
| Perceptive Advisors | 264,204 | $4,172,000 | 0.25% |